Method for preparing walnut antioxidant peptide through compound fermentation of probiotics

The extraction of walnut antioxidant peptides through the probiotic compound fermentation method solves the problem of insufficient utilization of walnut meal and complex and high cost of existing preparation methods, and achieves efficient and environmentally friendly preparation of antioxidant peptides, with good application prospects.

CN119020444APending Publication Date: 2024-11-26YUNNAN AGRICULTURAL UNIVERSITY
View PDF 0 Cites 3 Cited by

Patent Information

Application Number
CN202411441222.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-10-15
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

The insufficient utilization of walnut meal in the existing technology has led to challenges in the healthy and sustainable development of the walnut industry. The existing walnut antioxidant peptide preparation methods are complex in operation and high in cost, making it difficult to promote.

Method used

The cold-pressed walnut meal was crushed and mixed with water, and the probiotics were added for fermentation. The polypeptides of different molecular weight segments were extracted by ultrafiltration, and the polypeptides with antioxidant effect were screened out through antioxidant activity analysis.

Benefits of technology

It has achieved the preparation of walnut antioxidant peptides with simple operation, green and environmental protection, high efficiency and energy saving, high antioxidant activity, stable amino acid sequence of the peptide, and has good application prospects.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119020444A_ABST
    Figure CN119020444A_ABST
Patent Text Reader

Abstract

The invention discloses a method for preparing walnut antioxidant peptide through compound fermentation of probiotics. The method comprises the following steps: S1, crushing cold-pressed walnut meal to obtain walnut meal powder; s2, adding water into the walnut meal powder to obtain a walnut meal fermentation substrate; s3, respectively activating at least two or more probiotics, and adjusting the concentration of a bacterial solution to obtain two or more probiotic suspensions; s4, compounding at least two probiotic suspensions according to a ratio of 1: 1 to obtain a probiotic mixed bacterial liquid; s5, inoculating the probiotic mixed bacteria liquid into the walnut meal fermentation substrate according to the inoculation amount of 0.5-2%, fermenting to obtain a fermented product, and separating and extracting by an ultrafiltration method to obtain polypeptides with different molecular weight segments; and S6, carrying out antioxidant activity analysis on the polypeptides with different molecular weight segments, and screening to obtain the polypeptides with the antioxidant effect. The operation method is simple, convenient, green, environment-friendly, efficient and energy-saving, and has a good application prospect.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of walnut by-product development, and in particular to a method for preparing walnut antioxidant peptides by composite fermentation with probiotics. Background Art

[0002] Low-temperature walnut meal is a by-product produced during the cold-pressing production process of walnut oil, and its high-quality protein content is as high as 50% or more. Compared with the hot-pressing method, the protein in cold-pressed walnut meal is less denatured. The main component of walnut meal is gluten, which has a complete range of amino acids and is rich in nutrients such as minerals, dietary fiber, polyphenols, etc., which can provide sufficient carbon and nitrogen sources for fermentation bacteria. At present, walnut meal is mostly used for animal feed and fertilizer, and a small amount of walnut meal is also used to produce primary products such as walnut protein powder and protein milk, while the high-quality protein in walnut meal is not fully utilized. Therefore, strengthening the in-depth development and research of walnuts and walnut by-products is of great significance to the healthy and sustainable development of the walnut industry.

[0003] Chinese invention patent No. CN103497985B discloses a method for preparing walnut meal antioxidant peptides, which uses walnut meal protein, hydrolyzes it by enzymatic method to obtain protein hydrolysate, and then separates and purifies it by gel filtration chromatography and reversed-phase high-performance liquid chromatography to obtain antioxidant peptide products. However, this method is complicated to operate and costly, and is difficult to promote and apply.

[0004] The disclosure of the above background technology content is only used to assist in understanding the inventive concept and technical solution of the present invention. It does not necessarily belong to the prior art of this patent application. In the absence of clear evidence that the above content has been disclosed on the filing date of this patent application, the above background technology should not be used to evaluate the novelty and creativity of the present application. Summary of the invention

[0005] The object of the present invention is to provide a method for preparing walnut antioxidant peptides by composite fermentation of probiotics, so as to solve at least one of the above-mentioned background technical problems.

[0006] To solve the above problems, the technical solution of the present invention is achieved as follows:

[0007] A method for preparing walnut antioxidant peptides by probiotic composite fermentation, comprising the following steps:

[0008] S1. Crush and sieve the cold-pressed walnut meal to obtain walnut meal powder;

[0009] S2, adding water to the walnut meal powder so that the water content of the walnut meal is 50%-70%, and stirring evenly to obtain a semi-solid walnut meal fermentation matrix;

[0010] S3. Activate at least two or more probiotics respectively and adjust the concentration of the bacterial solution to 1.0×10 8 cfu / mL, and a suspension of two or more probiotics was obtained;

[0011] S4, compounding the at least two probiotic suspensions obtained in step S3 in a ratio of 1:1, and mixing them thoroughly to obtain a probiotic mixed bacterial solution;

[0012] S5, inoculating the probiotic mixed bacterial solution into the walnut meal fermentation matrix at an inoculation rate of 0.5%-2%, fermenting at 30-40° C. for 12-48 hours to obtain a fermentation product, and separating and extracting polypeptides of different molecular weight ranges by ultrafiltration;

[0013] S6. Analyze the antioxidant activity of the polypeptides of different molecular weight ranges obtained in step S5, and screen out polypeptides with antioxidant effects.

[0014] In some embodiments, step S6 includes:

[0015] S60. Conduct in vitro antioxidant activity assays on polypeptides of different molecular weight ranges to screen out polypeptide components with high in vitro antioxidant activity.

[0016] In some embodiments, step S6 further includes:

[0017] S61, identify walnut polypeptide sequences, perform molecular docking of the polypeptide sequences obtained after identification with Keap1 protein, and screen out novel peptides with high binding energy;

[0018] S62. The novel peptide with high binding energy was subjected to antioxidant test at the cellular level to further examine its antioxidant effect.

[0019] In some embodiments, step S3 comprises: inoculating frozen Lactobacillus bulgaricus, Lactobacillus casei, Streptococcus thermophilus, Lactobacillus plantarum, Lactobacillus acidophilus and Lactobacillus reuteri into MRS broth culture medium respectively, activating them in a 37° C. incubator for 24 hours to activate them to the third generation.

[0020] In some embodiments, step S3 comprises: activating Lactobacillus bulgaricus, Lactobacillus casei, Streptococcus thermophilus, Lactobacillus plantarum, Lactobacillus acidophilus and Lactobacillus reuteri respectively, and adjusting the concentration of the bacterial solution to 1.0×10 8 cfu / mL, and six probiotic suspensions were obtained.

[0021] In some embodiments, all probiotics are lactic acid bacteria.

[0022] In some embodiments, the in vitro antioxidant activity assay of polypeptides of different molecular weight segments comprises: ABTS free radical scavenging ability assay and DPPH free radical scavenging ability assay.

[0023] In some embodiments, the walnut polypeptide sequence identification comprises:

[0024] Based on the results of in vitro antioxidant assay, polypeptide components with MW < 1 kDa with good antioxidant activity were identified.

[0025] In some embodiments, step S5 comprises: vacuum freeze-drying the fermented product, dissolving it in deionized water, and fractionating and separating the walnut polypeptides by ultrafiltration membrane method.

[0026] In some embodiments, step S1 includes: crushing the cold-pressed walnut meal and passing it through a 60-mesh sieve to obtain walnut meal powder.

[0027] The beneficial effects of the technical solution of the present invention are:

[0028] Compared with the prior art, the method for preparing walnut antioxidant peptides by probiotic composite fermentation of the present invention is simple to operate, green and environmentally friendly, efficient and energy-saving, and has good application prospects; and the antioxidant peptides obtained by the method of the present invention have high antioxidant activity and stable peptide amino acid sequences.

[0029] It is to be understood that the foregoing general description and the following detailed description are exemplary and explanatory only and are not restrictive of the present disclosure. BRIEF DESCRIPTION OF THE DRAWINGS

[0030] In order to more clearly illustrate the technical solutions in the embodiments of the present invention or the prior art, the drawings required for use in the embodiments or the prior art description are briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without creative labor. The drawings herein are incorporated into the specification and constitute a part of this specification, showing embodiments consistent with the present invention, and together with the specification, are used to explain the principles of the present invention.

[0031] Figure 1A , Figure 1B The ABTS and DPPH free radical scavenging abilities of walnut polypeptides of different molecular weight segments obtained by the method of this example.

[0032] Figure 2A , Figure 2B The molecular docking results of two novel peptides APPTPPAPPK and PGAPGQGPR obtained by the method of this example and Keap1 protein (PDBID: 2FLU) are shown.

[0033] Figure 3A , Figure 3B They are Figure 2A , Figure 2B Mass spectra of two novel peptides.

[0034] Figure 4A , Figure 4B , Figure 4C The mixed peptides (MW < 1 kDa) obtained by the method of this example and Figure 2A , Figure 2B The effects of two novel peptides on cell viability.

[0035] Figure 5A , Figure 5B , Figure 5C The mixed peptides (MW < 1 kDa) obtained by the method of this example and Figure 2A , Figure 2B Protective effects of two novel peptides against oxidative damaged cells.

[0036] Fig. 6A , Figure 6B , Figure 6C The mixed peptides (MW < 1 kDa) obtained by the method of this example and Figure 2A , Figure 2B Effects of two novel peptides on SOD content in RAW264.7 cells induced by H2O2.

[0037] Fig. 7A , Figure 7B , Figure 7C The mixed peptides (MW < 1 kDa) obtained by the method of this example and Figure 2A , Figure 2B Effects of two novel peptides on MDA content in RAW264.7 cells induced by H2O2.

[0038] Fig. 8A , Figure 8B , Figure 8C The mixed peptides (MW < 1 kDa) obtained by the method of this example and Figure 2A , Figure 2B Effects of two novel peptides on H2O2-induced CAT content in RAW264.7 cells.

[0039] Fig.9A , Fig. 9B , Fig. 9C The mixed peptides (MW < 1 kDa) obtained by the method of this example and Figure 2A , Figure 2B Effects of two novel peptides on the intracellular GSH content of RAW264.7 cells induced by H2O2. DETAILED DESCRIPTION

[0040] In order to make the technical problems, technical solutions and beneficial effects to be solved by the embodiments of the present invention clearer and more understandable, and to enable those skilled in the art to better understand the solutions of the present invention, the technical solutions in the embodiments of the present invention will be described clearly and completely in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are only embodiments of a part of the present invention, not all embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work should fall within the scope of protection of the present invention.

[0041] It should be noted that the terms "first", "second", etc. in the specification and claims of the present invention are used to distinguish similar objects, and are not necessarily used to describe a specific order or sequence. It should be understood that the data used in this way can be interchanged where appropriate, so that the embodiments of the present invention described herein can be implemented in an order other than those described herein. In addition, the terms "including" and "having" and any of their variations are intended to cover non-exclusive inclusions, for example, a process, method, system, product or device that includes a series of steps or units is not necessarily limited to those steps or units that are clearly listed, but may include other steps or units that are not clearly listed or inherent to these processes, methods, products or devices.

[0042] The cold-pressed walnut meal involved in the embodiments can be directly purchased on the market.

[0043] The present invention provides a method for preparing walnut antioxidant peptides by probiotic composite fermentation, comprising the following steps:

[0044] Step S1, crushing the cold-pressed walnut meal and passing it through a 60-mesh sieve to obtain walnut meal powder;

[0045] Step S2, adding water to the walnut meal powder so that the water content of the walnut meal is 50%-70%, and stirring evenly to obtain a semi-solid walnut meal fermentation matrix;

[0046] Step S3: Activate at least two or more probiotics respectively and adjust the concentration of the bacterial solution to 1.0×10 8 cfu / mL, and a suspension of two or more probiotics was obtained;

[0047] In the embodiment of the present invention, six kinds of probiotics were activated respectively, and the concentration of the bacterial solution was adjusted to 1.0×10 8cfu / mL, and six kinds of probiotic suspensions were obtained; as a preferred embodiment, the six kinds of probiotics were Lactobacillus bulgaricus (CICC6098), Lactobacillus casei (CICC 23184), Streptococcus thermophilus (CICC 20388), Lactobacillus plantarum (CICC 194165), Lactobacillus acidophilus (CICC 20244), Lactobacillus reuteri (CICC 6131), and the six kinds of probiotics were purchased from the China Industrial Microbiological Culture Collection Administration Center. It should be noted that in the embodiments of the present invention, the probiotics are all lactic acid bacteria.

[0048] Specifically, frozen Lactobacillus bulgaricus, Lactobacillus casei, Streptococcus thermophilus, Lactobacillus plantarum, Lactobacillus acidophilus and Lactobacillus reuteri were inoculated into MRS broth medium (lactic acid bacteria medium) respectively, and activated in a 37°C incubator for 24 hours. According to this method, the strains were activated to the third generation, and then 1 mL of the third generation bacterial solution was inoculated into 100 mL of MRS broth medium for expansion culture, and cultured at 37°C for 12 hours to obtain fermentation seed solutions of various probiotics, and the concentrations of various bacterial solutions were adjusted to 1.0×10 8 cfu / mL, and six probiotic bacterial suspensions were obtained.

[0049] Step S4, compounding the at least two probiotic suspensions obtained in step S3 in a ratio of 1:1, and mixing them thoroughly to obtain a probiotic mixed bacterial solution;

[0050] In an embodiment of the present invention, six probiotic bacterial suspensions, including Lactobacillus bulgaricus, Lactobacillus casei, Streptococcus thermophilus, Lactobacillus plantarum, Lactobacillus acidophilus and Lactobacillus reuteri, are compounded in a ratio of 1:1:1:1:1:1, and are fully mixed to obtain a probiotic mixed bacterial liquid. It should be noted that the probiotic mixed bacterial liquid cannot be mixed with other strains other than probiotics, and the probiotics are all lactic acid bacteria.

[0051] Step S5, inoculating the probiotic mixed bacterial liquid into the walnut meal fermentation matrix at an inoculation rate of 0.5%-2%, and fermenting at 30-40°C for 12-48 hours to obtain a fermentation product; after vacuum freeze-drying the fermentation product, ultrafiltration is used to separate and extract polypeptides of different molecular weight ranges.

[0052] Step S6: analyzing the antioxidant activity of the polypeptides of different molecular weight ranges obtained in step S5, and screening out polypeptides with antioxidant effects.

[0053] In some embodiments, step S6 includes:

[0054] S60, in vitro antioxidant activity assay

[0055] The polypeptides of different molecular weight ranges are subjected to in vitro antioxidant activity assay to screen out polypeptide components with good in vitro antioxidant activity.

[0056] In some embodiments, step S6 further includes:

[0057] S61, identify walnut polypeptide sequences, perform molecular docking of the polypeptide sequences obtained after identification with Keap1 protein, and screen out novel peptides with high binding energy;

[0058] S62. The novel peptide with high binding energy was subjected to antioxidant test at the cellular level to further examine its antioxidant effect.

[0059] Among them, S61 is as follows:

[0060] S610, Walnut polypeptide sequence identification

[0061] The selected polypeptide components with good in vitro antioxidant activity (MW < 1 kDa) were dissolved, desalted using a Waters SEP-PAK C18 solid phase extraction column, freeze-dried, reconstituted with formic acid water, centrifuged, and the supernatant was taken for detection.

[0062] Chromatographic separation: Liquid A is 0.1% formic acid aqueous solution, and liquid B is 0.1% formic acid acetonitrile aqueous solution (acetonitrile is 80%). The liquid chromatography column (50 μm*150 mm, Acclaim PepMapTM RSLC, thermo scientific Technology Inc.) is equilibrated with 92% liquid A, and the injection volume is 1 μL, and the separation is performed on the chromatographic column.

[0063] Mass spectrometry identification: After HPLC separation, mass spectrometry analysis was performed using a Thermo QE HF mass spectrometer. Analysis time: 120 min; detection method: positive ion; scanning range 400-1800, primary resolution 60000, secondary resolution 15000, collision energy CE28eV.

[0064] S611, Screening of Antioxidant Peptides

[0065] The peptide sequences obtained after identification were molecularly docked with Keap1 protein to screen out new peptides with high binding energy.

[0066] In some embodiments, S62 is specifically as follows:

[0067] After solid phase synthesis of two peptides with higher molecular docking binding energy (amino acid sequences: APPTPPAPPK and PGAPGQGPR), in vitro antioxidant activity assay was performed; in some embodiments, the assay included ABTS and DPPH free radical scavenging ability assay.

[0068] In some embodiments, it also includes: a cellular antioxidant test on walnut polypeptides; specifically, a cytotoxicity test is performed on the mixed peptide with MW <1kDa and two novel peptides (APPTPPAPPK, PGAPGQGPR) to detect their effects on cell viability. At the same time, the protective effects of the mixed peptide with MW <1kDa and the two novel peptides on H2O2-induced oxidative damage of RAW264.7 cells are determined, and their effects on the levels of superoxide dismutase (SOD), reduced glutathione (GSH), catalase (CAT) and lipid peroxide (MDA) in oxidatively damaged cells are determined.

[0069] The following will be described in detail using 100g and 50g walnut meal powder as examples.

[0070] Example 1

[0071] Taking 100g of walnut meal powder as an example, the method for preparing walnut antioxidant peptides by probiotic composite fermentation in an embodiment of the present invention comprises the following steps:

[0072] The cold-pressed walnut meal was crushed and passed through a 60-mesh sieve to obtain walnut meal powder; 100 g of the walnut meal powder was put into a conical flask, and 100 mL of water was added and stirred to obtain a semi-solid walnut meal fermentation matrix.

[0073] Lactobacillus bulgaricus, Lactobacillus casei, Streptococcus thermophilus, Lactobacillus plantarum, Lactobacillus acidophilus and Lactobacillus reuteri, a total of six probiotics, are activated to the third generation respectively; then, the six bacterial liquids are mixed evenly according to a compounding ratio of 1:1:1:1:1:1 to obtain a probiotic mixed bacterial liquid, and the probiotic mixed bacterial liquid is inoculated into the walnut meal fermentation matrix at an inoculation amount of 2%, and fermented at 30°C for 48 hours to obtain a fermented product. It should be noted that the probiotics in Example 1 are six kinds, but are not limited to six kinds, and can be two or more; they are also not limited to Lactobacillus bulgaricus, Lactobacillus casei, Streptococcus thermophilus, Lactobacillus plantarum, Lactobacillus acidophilus and Lactobacillus reuteri in Example 1, and other probiotics are possible, but the probiotics must be lactic acid bacteria.

[0074] The fermented product was freeze-dried in vacuum and dissolved in deionized water. The walnut polypeptide was fractionated and separated by ultrafiltration membrane method to obtain polypeptide components in five molecular weight ranges: MW>10kDa, 5-10kDa, 3-5kDa, 1-3kDa and MW<1kDa.

[0075] Determination of the in vitro antioxidant activity of peptides of different molecular weight ranges, including: ABTS free radical scavenging ability determination and DPPH free radical scavenging ability determination;

[0076] Among them, the ABTS free radical scavenging ability is determined as follows:

[0077] Mix 2.45mmol / L potassium persulfate and 7mmol / L ABTS stock solution in a 1:1 ratio and react in the dark for 14-16 hours. Dilute the ABTS·+ solution with 5mM PBS with a pH value of 7.4, and the absorbance at 734nm is about 0.7. Finally, mix the samples of different concentrations with the diluted ABTS free radical working solution in a 1:1 ratio and react in the dark for 10 minutes at room temperature. The calculation formula is as follows:

[0078]

[0079] Where: AS is the absorbance value of the sample group, A0 is the absorbance value of the blank group.

[0080] The DPPH free radical scavenging ability was determined as follows:

[0081] Dissolve 4 mg DPPH in 100 mL anhydrous ethanol to prepare 0.1 mmol / L DPPH ethanol solution, and store it in a sealed container at 4°C in a light-proof refrigerator. Take 0.5 mL of the sample solution of MW<1kDa, 1-3kDa, 3-5kDa, 5-10kDa, and MW>10kDa, mix it with 0.5 mL of 0.1 mmol / L ethanol solution in a centrifuge tube, react for 50 minutes in a light-proof environment, and measure the absorbance at a wavelength of 517 nm after centrifugation.

[0082]

[0083] Where: A 空 For the blank tube, anhydrous ethanol was used to replace 0.1mmol / L DPPH; A 对 0.5mL of anhydrous ethanol and 0.5mL of 0.1mmol / L DPPH ethanol solution; A 样 0.5 mL of sample solution and 0.5 mL of 0.1 mmol / L DPPH ethanol solution.

[0084] The results are as follows Figure 1A , Figure 1B As shown in the figure, NF means no fermentation, and F means probiotic fermentation. Figure 1A is the DPPH free radical scavenging rate; Figure 1B is the ABTS free radical scavenging rate; compared with the unfermented, the antioxidant capacity of the walnut peptides obtained after probiotic fermentation was significantly improved, and the scavenging rates of peptides in different molecular weight ranges on ABTS and DPPH free radicals increased with the increase of peptide concentration. Among them, the peptide component with MW < 1kDa showed the best ABTS and DPPH free radical scavenging ability, while the free radical scavenging ability of the peptide component with MW > 10kDa was the weakest.

[0085] The MW <1kDa walnut mixed polypeptide was subjected to cytotoxicity test, and the specific operation was as follows:

[0086] RAW 264.7 cells in the logarithmic growth phase were seeded in 96-well plates and the number of cells per well was adjusted to 1.0 × 10 4 The concentration of cells was 100 μL / well. After 24 hours of culture, 200 μL of culture medium was added to the control group. The experimental group treated cells with peptide solutions at concentrations of 100, 200, 300, 400, 500, 600, 700, and 800 μg / mL. The blank group was added with peptide solution without adding RAW 264.7 cells. After 24 hours of culture, 100 μL of 0.25 mg / mL MTT was added to each well. After another 4 hours of culture, the culture medium was replaced with DMSO, and the OD value was measured at a wavelength of 490 nm using an enzyme reader.

[0087] Calculated using the following formula:

[0088]

[0089] Where: As—absorbance value of the experimental group; Ac—absorbance value of the control group; Ab—absorbance value of the blank group.

[0090] The results are as follows Figure 4A It can be seen that with the increase of peptide concentration, the cell survival rate gradually decreased, indicating that high concentrations of walnut peptides (400μg / mL and 800μg / mL) reduced the cell survival rate. It can be seen that when determining the antioxidant activity of mixed peptides, it is more appropriate to select walnut mixed peptide concentrations of 50μg / mL, 100μg / mL, and 200μg / mL.

[0091] Evaluation of the effect of MW < 1 kDa walnut mixed peptides on the survival rate of oxidatively damaged cells. The H2O2-induced oxidative damage model of RAW264.7 cells was used to evaluate the protective effect of MW < 1 kDa mixed peptides on cell oxidative damage. RAW 264.7 cells in the logarithmic growth phase were taken and 5.0 × 10 4 Each cell was inoculated in a 96-well plate, 100 μL per well. After 24 hours of culture, the cells were pre-cultured with different concentrations of peptide solution for 6 hours, and then 100 μL of culture medium containing H2O2 (700 μmol / mL) was added for 4 hours. After the end, the cells were washed with PBS and replaced with new culture medium for another 2 hours. Then the peptide solution was tested for its preventive effect on H2O2-induced RAW 264.7 cell damage.

[0092] The results are as follows Figure 5AAs shown in the figure, after the cells were treated with H2O2 at a concentration of 700μmol / L, the cell survival rate decreased significantly, and the survival rate was 53.46%. After being treated with different concentrations of MW <1kDa walnut polypeptide, the survival rate of the cells treated with H2O2 was significantly increased, and it was dose-dependent; when the concentration of walnut polypeptide was 200μg / mL, the cell survival rate was 66.3%, which was significantly higher than that of the model group.

[0093] Evaluation of the effects of MW < 1kDa walnut mixed peptides on the contents of SOD, MDA, CAT, and GSH in RAW264.7 cells induced by H2O2.

[0094] Specifically, in order to further verify the antioxidant capacity of walnut mixed polypeptides with MW < 1kDa, the Elisa method was used to determine the content of SOD, MDA, CAT, and GSH in cells after H2O2-induced oxidative damage after walnut polypeptide treatment. The specific operation was carried out according to the instructions of the Elisa detection kit for SOD, MDA, CAT, and GSH. The results are as follows Figures 6A-9C As shown in the results, compared with the control group without induced oxidative damage, the SOD content in the model group decreased significantly, indicating that the cells were damaged. When different concentrations of walnut peptides with MW < 1kDa were used to protect the oxidatively damaged cells, it can be seen that with the increase of peptide concentration, the activity of SOD enzyme in the cells also increased ( Fig. 6A This indicates that walnut mixed polypeptides with MW < 1 kDa can increase the enzyme activity of SOD in cells, thereby protecting cells from oxidative damage.

[0095] MDA is an important indicator of cell oxidative damage. The higher its content, the more serious the cell oxidative damage. Fig. 7A It can be seen that after H2O2 induced cell oxidative damage, the MDA content in the model group increased significantly compared with the control group without induced damage, while the MDA in the cells was significantly reduced after the cells were treated with different concentrations of MW < 1kDa walnut mixed polypeptides, and the MDA content in the cells decreased in a dose-dependent manner with the increase of polypeptide concentration. This indicates that walnut polypeptides can inhibit lipid peroxidation in cells and reduce the production of malondialdehyde in cells, thus having a certain protective effect on cell oxidative damage.

[0096] The results of the enzyme activity determination of intracellular CAT and GSH are as follows Fig. 8A and Fig.9AAs shown in the figure, the enzyme activities of CAT and GSH in the model group treated with H2O2 were significantly reduced, while after treatment with different concentrations of walnut peptides, the enzyme activities of CAT and GSH in the oxidatively damaged cells were significantly increased, and showed a dose-dependent trend. This shows that MW <1kDa walnut mixed polypeptides can effectively increase the enzyme activities of CAT and GSH in oxidatively damaged cells and play a protective role on oxidatively damaged cells.

[0097] Example 2

[0098] Taking 50g of walnut meal powder as an example, the method for preparing walnut antioxidant peptides by probiotic composite fermentation in the embodiment of the present invention comprises the following steps:

[0099] The cold-pressed walnut meal was crushed and passed through a 60-mesh sieve to obtain walnut meal powder; 50 g of the walnut meal powder was put into a conical flask, and 100 mL of water was added and stirred to obtain a semi-solid walnut meal fermentation matrix.

[0100] Six probiotics, namely Lactobacillus bulgaricus, Lactobacillus casei, Streptococcus thermophilus, Lactobacillus plantarum, Lactobacillus acidophilus and Lactobacillus reuteri, are activated to the third generation respectively. Then, the six bacterial solutions are mixed evenly at a compounding ratio of 1:1:1:1:1:1 to obtain a probiotic mixed bacterial solution, and the probiotic mixed bacterial solution is inoculated into the walnut meal fermentation matrix at an inoculation amount of 1%, and fermented at 37° C. for 24 hours to obtain a fermentation product, and polypeptides of different molecular weight segments are separated and extracted by ultrafiltration.

[0101] The in vitro antioxidant activity of polypeptides of different molecular weight ranges was determined. The specific method is described in the above Example 1 and will not be repeated here.

[0102] The peptide sequence was identified, and the peptide components with MW < 1 kDa with good antioxidant activity were identified based on the results of in vitro antioxidant assay. The peptide components with MW < 1 kDa were dissolved in deionized water, desalted using a Waters SEP-PAK C18 solid phase extraction column, and freeze-dried; reconstituted with formic acid water, centrifuged, and the supernatant was taken for detection.

[0103] Specifically, the chromatographic separation was performed, including: liquid A was 0.1% formic acid aqueous solution, liquid B was 0.1% formic acid acetonitrile aqueous solution (acetonitrile was 80%). A liquid chromatography column (50 μm*150 mm, Acclaim PepMapTM RSLC, thermo scientific Technology Inc.) was balanced with 92% liquid A, the injection volume was 1 μL, and the separation was performed on the chromatographic column.

[0104] Mass spectrometry identification was performed, including: high performance liquid chromatography separation followed by mass spectrometry analysis using a Thermo QE HF mass spectrometer, analysis time: 120 min. Detection method: positive ion. Scanning range 400-1800, primary resolution 60000, secondary resolution 15000, collision energy CE28eV.

[0105] A total of 121 peptides were detected from the fractions with MW < 1 kDa.

[0106] Molecular docking and screening of antioxidant peptides were performed. 121 peptides were screened for unreported peptide sequences based on the identified peptide amino acid sequences with the help of the bioactive peptide database BIOPEP-UWM. The peptide activity was then measured and scored using the PeptideRanker website. Generally, peptides with a score > 0.5 were bioactive peptides. Finally, the separated and identified peptide sequences were screened for antioxidant peptides using molecular docking technology. Each peptide sequence was molecularly docked with the Keap1 protein (PDB ID: 2FLU). The molecular docking results are shown in Figure 2. Figure 2A , Figure 2B As shown in Table 1, two novel peptides with better binding energy were obtained: APPTPPAPPK ( Figure 2A ) and PGAPGQGPR( Figure 2B ). The mass spectra of the two new peptides are shown in Figure 3A , Figure 3B shown.

[0107] Table 1 Docking results of two novel peptides with Keap1 protein and hydrogen bonding amino acids

[0108]

[0109] The cell experiments of the novel peptides APPTPPAPPK and PGAPGQGPR are as follows:

[0110] The two peptides with the best molecular docking binding energy (APPTPPAPPK and PGAPGQGPR) were solid-phase synthesized and then subjected to cytotoxicity test. The cytotoxicity test method is the same as in Example 1 and will not be repeated here. Figure 4B , Figure 4C The results showed that for peptide 1 (APPTPPAPPK) and peptide 2 (PGAPGQGPR), high concentrations of walnut peptides (400 μg / mL and 800 μg / mL) reduced the cell survival rate to a certain extent. Therefore, in subsequent cell experiments, it is more appropriate to select peptide concentrations of 50 μg / mL, 100 μg / mL, and 200 μg / mL.

[0111] The protective effects of two novel peptides (APPTPPAPPK and PGAPGQGPR) on cell oxidative damage were evaluated using the H2O2-induced oxidative damage model of RAW264.7 cells. The experimental steps were the same as those in Example 1 and will not be described in detail. Figure 5B , Figure 5C As shown, after the cells were treated with H2O2 at a concentration of 700 μmol / L, the cell survival rate decreased significantly to only 53.46%. After being treated with different concentrations of the novel peptide, the survival rate of the cells treated with H2O2 was significantly increased, and the cell survival rate could be increased to about 80%.

[0112] The effects of the novel peptides APPTPPAPPK and PGAPGQGPR on the content of SOD, MDA, CAT, and GSH in RAW264.7 cells induced by H2O2 were evaluated; specifically, in order to further verify the antioxidant capacity of the two novel peptides, the Elisa method was used to determine the content of SOD, MDA, CAT, and GSH in cells after H2O2-induced oxidative damage after walnut peptide treatment. The specific operation steps were carried out according to the instructions for use of the Elisa kits for SOD, MDA, CAT, and GSH. The results are shown in Figures 6A-9C As shown in the results, compared with the control group without induced oxidative damage, the SOD content in the model group decreased significantly. When the oxidatively damaged cells were treated with different concentrations of the new peptide, it can be seen that with the increase of peptide concentration, the intracellular SOD enzyme activity also increased (such as Figure 6B , Figure 6C ), indicating that the fermented walnut peptides can increase the enzyme activity of SOD in cells, thereby protecting cells from oxidative damage.

[0113] Similarly, the results of MDA are given by Figure 7B , Figure 7C It can be seen that after H2O2 induced cellular oxidative damage, the MDA content in the model group increased significantly compared with the control group without induced damage; and after the cells were treated with different concentrations of the novel peptide, the MDA in the cells decreased significantly, and with the increase of peptide concentration, the MDA content in the cells decreased in a dose-dependent manner. This indicates that walnut peptides can inhibit lipid peroxidation in cells and reduce the production of malondialdehyde in cells, thus having a certain protective effect on cell oxidative damage.

[0114] The results of the enzyme activity determination of intracellular CAT and GSH are as follows Figure 8B , Figure 8C and Fig. 9B , Fig. 9CAs shown in the figure, it can be seen that the enzyme activities of CAT and GSH in the model group treated with H2O2 were significantly reduced, while after treatment with different concentrations of walnut peptides, the enzyme activities of CAT and GSH in the oxidatively damaged cells were significantly increased, and showed a dose-dependent trend. This shows that the two new walnut peptides can effectively increase the enzyme activities of CAT and GSH in oxidatively damaged cells and play a protective role on oxidatively damaged cells.

[0115] The implementation method of the present invention combines the fermentation of multiple probiotics in synergy, and utilizes the metabolic activity of microorganisms to decompose and transform the raw materials. The protease produced by the probiotics during the fermentation process can effectively degrade the macromolecular protein in the walnut meal and generate small molecule peptides. These small molecule peptides not only retain the nutritional components of the protein, but also have good solubility, hygroscopicity and emulsification, thereby improving the nutritional value of the walnut meal and making it easier to be absorbed and utilized by the human body. In addition, some new bioactive substances may be produced during the probiotic fermentation process, and the small molecule peptides themselves also have certain biological activities, such as anti-oxidation, antibacterial, and blood pressure lowering. The presence of these bioactive substances enhances the health benefits of the fermentation products and makes them have a wider range of application potential. New antioxidant peptides can be obtained by the method of the present invention, and the antioxidant activity is high, the peptide segment amino acid sequence is stable, and the operation method is simple, green and environmentally friendly, and energy-efficient, and has a good application prospect.

[0116] Those skilled in the art will readily appreciate other embodiments of the present invention after considering the specification and practicing the invention disclosed herein. This application is intended to cover any variations, uses or adaptations of the present invention that follow the general principles of the present invention and include common knowledge or customary techniques in the art that are not disclosed in this disclosure. The specification and examples are to be considered as exemplary only, and the true scope and spirit of the present invention are indicated by the following claims.

[0117] It is understandable that the above content is a further detailed description of the invention in combination with specific / preferred embodiments, and it cannot be determined that the specific implementation of the invention is limited to these descriptions. For ordinary technicians in the technical field to which the invention belongs, without departing from the concept of the invention, they can also make several substitutions or modifications to the described embodiments, and these substitutions or modifications should be deemed to belong to the scope of protection of this patent. In the description of this specification, the description of reference terms "an embodiment", "some embodiments", "preferred embodiments", "examples", "specific examples", or "some examples" means that the specific features, structures, materials or characteristics described in combination with the embodiment or example are included in at least one embodiment or example of the present invention.

[0118] In this specification, the schematic representations of the above terms do not necessarily refer to the same embodiment or example. Moreover, the specific features, structures, materials or characteristics described may be combined in any one or more embodiments or examples in a suitable manner. In addition, those skilled in the art may combine and combine the different embodiments or examples described in this specification and the features of the different embodiments or examples, without contradicting each other. Although the embodiments and advantages of the invention have been described in detail, it should be understood that various changes, substitutions and modifications may be made herein without departing from the scope defined by the appended claims.

[0119] Furthermore, the scope of the invention is not intended to be limited to the specific embodiments of the processes, machines, manufactures, compositions of matter, means, methods, and steps described in the specification. One of ordinary skill in the art will readily appreciate that the above disclosures, processes, machines, manufactures, compositions of matter, means, methods, or steps currently existing or to be developed that perform substantially the same functions as the corresponding embodiments described herein or obtain substantially the same results as the embodiments described herein may be utilized. Therefore, the appended claims are intended to include such processes, machines, manufactures, compositions of matter, means, methods, or steps within their scope.

Claims

1. A method for preparing walnut antioxidant peptides by probiotic composite fermentation, characterized in that: The following steps are involved: S1. Crush and sieve the cold-pressed walnut meal to obtain walnut meal powder; S2, adding water to the walnut meal powder so that the water content of the walnut meal is 50%-70%, and stirring evenly to obtain a semi-solid walnut meal fermentation matrix; S3. Activate at least two or more probiotics respectively and adjust the concentration of the bacterial solution to 1.0×10 8 cfu / mL, and a suspension of two or more probiotics was obtained; S4, compounding the at least two probiotic suspensions obtained in step S3 in a ratio of 1:1, and mixing them thoroughly to obtain a probiotic mixed bacterial solution; S5, inoculating the probiotic mixed bacterial solution into the walnut meal fermentation matrix at an inoculation rate of 0.5%-2%, fermenting at 30-40° C. for 12-48 hours to obtain a fermentation product, and separating and extracting polypeptides of different molecular weight ranges by ultrafiltration; S6. Analyze the antioxidant activity of the polypeptides of different molecular weight ranges obtained in step S5, and screen out polypeptides with antioxidant effects.

2. The method for preparing walnut antioxidant peptides by probiotic composite fermentation as claimed in claim 1, characterized in that: Step S6 includes: S60. Conduct in vitro antioxidant activity assays on polypeptides of different molecular weight ranges to screen out polypeptide components with high in vitro antioxidant activity.

3. The method for preparing walnut antioxidant peptides by probiotic composite fermentation as claimed in claim 2, characterized in that: Step S6 also includes: S61, identify walnut polypeptide sequences, perform molecular docking of the polypeptide sequences obtained after identification with Keap1 protein, and screen out novel peptides with high binding energy; S62. The novel peptide with high binding energy was subjected to antioxidant test at the cellular level to further examine its antioxidant effect.

4. The method for preparing walnut antioxidant peptides by probiotic composite fermentation as claimed in claim 1, characterized in that: In step S3, frozen Lactobacillus bulgaricus, Lactobacillus casei, Streptococcus thermophilus, Lactobacillus plantarum, Lactobacillus acidophilus and Lactobacillus reuteri are inoculated into MRS broth culture medium respectively, and activated in a 37° C. incubator for 24 hours to the third generation.

5. The method for preparing walnut antioxidant peptides by probiotic composite fermentation as claimed in claim 1, characterized in that: In step S3, Lactobacillus bulgaricus, Lactobacillus casei, Streptococcus thermophilus, Lactobacillus plantarum, Lactobacillus acidophilus and Lactobacillus reuteri were activated respectively, and the concentration of the bacterial solution was adjusted to 1.0×10 8 cfu / mL, and six probiotic suspensions were obtained.

6. The method for preparing walnut antioxidant peptides by probiotic composite fermentation as claimed in claim 1, characterized in that: All probiotics are lactic acid bacteria.

7. The method for preparing walnut antioxidant peptides by probiotic composite fermentation as claimed in claim 2, characterized in that: The in vitro antioxidant activity determination of polypeptides of different molecular weight segments includes: ABTS free radical scavenging ability determination and DPPH free radical scavenging ability determination.

8. The method for preparing walnut antioxidant peptides by probiotic composite fermentation as claimed in claim 3, characterized in that: The walnut polypeptide sequence identification comprises: Based on the results of in vitro antioxidant assay, polypeptide components with MW < 1 kDa with good antioxidant activity were identified.

9. The method for preparing walnut antioxidant peptides by probiotic composite fermentation as claimed in claim 1, characterized in that: Step S5 comprises: vacuum freeze-drying the fermented product, dissolving it in deionized water, and fractionating and separating the walnut polypeptide by ultrafiltration membrane method.

10. The method for preparing walnut antioxidant peptides by probiotic composite fermentation according to claim 1, characterized in that: In step S1, the cold-pressed walnut meal is crushed and passed through a 60-mesh sieve to obtain walnut meal powder.

Citation Information

Cited By

  • High-quality lamb liver powder capable of being used as dietary additive and preparation method of high-quality lamb liver powder

    CN120549195A

  • Walnut peptide product with high antioxidant activity as well as preparation method and application of walnut peptide product

    CN122608689A

  • A walnut peptide product with high antioxidant activity and a preparation method and application thereof

    CN122878377A